Effects of montelukast sodium chewable tablets on the tonsils and adenoids in children with OSAHS
10.3969/j.issn.1005-1678.2017.04.104
- VernacularTitle:孟鲁司特钠咀嚼片对OSAHS患儿扁桃体及腺样体的影响
- Author:
Shuqin SHAN
;
Kejun XIA
- Keywords:
montelukast sodium chewable tablets;
obstructive sleep apnea-hypopnea syndrome;
children;
tonsil;
adenoid
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(4):314-316
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the montelukast sodium chewable tablets for the treatment of obstructive sleep apnea hypopnea syndrome(OSAHS)patients and treatment of tonsil and adenoid effect.Methods 84 cases of OSAHS patients in our hospital from January 2014 to August 2016 were randomly divided into the observation group and the control group,42 cases in each group.The control group was treated with conventional symptomatic treatment,on this basis,the patients in the observation group received montelukast sodium chewable tablets treatment,compared the two groups of the total efficiency,and compared before and after treatment of symptoms total score,apnea hypopneaIndex(AHI),the lowest arterial oxygen saturation(LSaO2),and adenoid and tonsil classification indexing.Results the total efficiency of observation group(90.48％)was significantly higher than the control group(69.04％,χ2=5.97,P<0.05); after treatment,the observation group of the total symptom score and AHI were significantly lower than the control group(P<0.05),LSaO2 was significantly higher than the control group(P<0.05),adenoid grade one and grade two were significantly higher than the control group(χ2=9.82,P<0.05),there was no significant difference between the one and two degrees of tonsil dividing ratio.Conclusion The clinical efficacy of montelukast sodium chewable tablets in the treatment of children with OSAHS is significant,can effectively reduce the volume of tonsil and adenoid body,and improve the clinical symptoms and sleep treatment significantly,which is worthy of clinical promotion.
